Efficacy and Safety of Naftopidil in Patients With Neurogenic Lower Urinary Tract Dysfunction: An 8-Week, Active-Controlled, Stratified-Randomized, Double-Blind, Double-Dummy, Parallel Group, Noninferiority, Multicenter Design.

CONCLUSION: Naftopidil was not inferior to tamsulosin as a therapeutic drug for patients with neurogenic LUTD and had a similar safety profile. PMID: 32615679 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/32615679?dopt=Abstract

Source: International Neurourology Journal - July 4, 2020 Category: Urology & Nephrology Tags: Int Neurourol J Source Type: research